down arrow

Guiyang Xintian Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002QB5
CNY
10.50
0.74 (7.58%)

Dec 05

SHE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Guiyang Xintian Pharmaceutical Co., Ltd.
Why is Guiyang Xintian Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 1.65% and Operating profit at -22.97% over the last 5 years
2
The company has declared Negative results for the last 10 consecutive quarters
  • NET SALES(HY) At CNY 351.66 MM has Grown at -18.98%
  • NET PROFIT(HY) At CNY 5.79 MM has Grown at -80.92%
  • PRE-TAX PROFIT(Q) At CNY 1.81 MM has Fallen at -89.82%
3
With ROE of 2.34%, it has a expensive valuation with a 2.01 Price to Book Value
  • Over the past year, while the stock has generated a return of 0.00%, its profits have fallen by -57.2%
  • At the current price, the company has a high dividend yield of 1
4
Underperformed the market in the last 1 year
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Guiyang Xintian Pharmaceutical Co., Ltd. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Guiyang Xintian Pharmaceutical Co., Ltd.
-100.0%
0.57
42.46%
China Shanghai Composite
15.19%
1.01
15.10%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
1.65%
EBIT Growth (5y)
-22.97%
EBIT to Interest (avg)
8.10
Debt to EBITDA (avg)
3.44
Net Debt to Equity (avg)
0.37
Sales to Capital Employed (avg)
0.52
Tax Ratio
12.73%
Dividend Payout Ratio
42.11%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.47%
ROE (avg)
8.54%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
86
Industry P/E
Price to Book Value
2.01
EV to EBIT
139.78
EV to EBITDA
54.28
EV to Capital Employed
1.74
EV to Sales
3.69
PEG Ratio
NA
Dividend Yield
0.97%
ROCE (Latest)
1.25%
ROE (Latest)
2.34%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
DEBT-EQUITY RATIO (HY)

Lowest at 36.03 %

-29What is not working for the Company
NET SALES(HY)

At CNY 351.66 MM has Grown at -18.98%

NET PROFIT(HY)

At CNY 5.79 MM has Grown at -80.92%

PRE-TAX PROFIT(Q)

At CNY 1.81 MM has Fallen at -89.82%

ROCE(HY)

Lowest at 2.52%

CASH AND EQV(HY)

Lowest at CNY 194.43 MM

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.33%

Here's what is working for Guiyang Xintian Pharmaceutical Co., Ltd.
Debt-Equity Ratio
Lowest at 36.03 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Depreciation
Highest at CNY 11.45 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (CNY MM)

Depreciation
At CNY 11.45 MM has Grown at inf%
period on period (QoQ)
MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (CNY MM)

Here's what is not working for Guiyang Xintian Pharmaceutical Co., Ltd.
Net Sales
At CNY 163.31 MM has Fallen at -37.23%
Year on Year (YoY)
MOJO Watch
Near term sales trend is extremely negative

Net Sales (CNY MM)

Pre-Tax Profit
At CNY 1.81 MM has Fallen at -89.82%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit
At CNY 1.59 MM has Fallen at -89.26%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (CNY MM)

Net Sales
Lowest at CNY 163.31 MM and Fallen
In each period in the last five periods
MOJO Watch
Near term sales trend is very negative

Net Sales (CNY MM)

Cash and Eqv
Lowest at CNY 194.43 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debtors Turnover Ratio
Lowest at 2.33%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."